These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38342128)

  • 1. Repeat placental growth factor-based testing in women with suspected preterm pre-eclampsia (PARROT-2): a multicentre, parallel-group, superiority, randomised controlled trial.
    Hurrell A; Webster L; Sparkes J; Battersby C; Brockbank A; Clark K; Duhig KE; Gill C; Green M; Hunter RM; Seed PT; Vowles Z; Myers J; Shennan AH; Chappell LC;
    Lancet; 2024 Feb; 403(10427):619-631. PubMed ID: 38342128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial.
    Duhig KE; Myers J; Seed PT; Sparkes J; Lowe J; Hunter RM; Shennan AH; Chappell LC;
    Lancet; 2019 May; 393(10183):1807-1818. PubMed ID: 30948284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental growth fActor Repeat sampling for Reduction of adverse perinatal Outcomes in women with suspecTed pre-eclampsia: study protocol for a randomised controlled trial (PARROT-2).
    Hurrell A; Sparkes J; Duhig K; Seed PT; Myers J; Battersby C; Clark K; Green M; Hunter RM; Shennan AH; Chappell LC; Webster L
    Trials; 2022 Sep; 23(1):722. PubMed ID: 36056408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial.
    Chappell LC; Brocklehurst P; Green ME; Hunter R; Hardy P; Juszczak E; Linsell L; Chiocchia V; Greenland M; Placzek A; Townend J; Marlow N; Sandall J; Shennan A;
    Lancet; 2019 Sep; 394(10204):1181-1190. PubMed ID: 31472930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Planned delivery or expectant management for late preterm pre-eclampsia in low-income and middle-income countries (CRADLE-4): a multicentre, open-label, randomised controlled trial.
    Beardmore-Gray A; Vousden N; Seed PT; Vwalika B; Chinkoyo S; Sichone V; Kawimbe AB; Charantimath U; Katageri G; Bellad MB; Lokare L; Donimath K; Bidri S; Goudar S; Sandall J; Chappell LC; Shennan AH;
    Lancet; 2023 Jul; 402(10399):386-396. PubMed ID: 37393919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental growth factor in assessment of women with suspected pre-eclampsia to reduce maternal morbidity: a stepped wedge cluster randomised control trial (PARROT Ireland).
    Hayes-Ryan D; Khashan AS; Hemming K; Easter C; Devane D; Murphy DJ; Hunter A; Cotter A; McAuliffe FM; Morrison JJ; Breathnach FM; Dempsey E; Kenny LC; O'Donoghue K;
    BMJ; 2021 Aug; 374():n1857. PubMed ID: 34389547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeat Placental Growth Factor-Based Testing in Women With Suspected Preterm Preeclampsia: A Stratified Analysis of the PARROT-2 Trial.
    Hurrell A; Webster L; Sparkes J; Battersby C; Brockbank A; Clark K; Duhig KE; Gill C; Green M; Hunter RM; Seed PT; Vowles Z; Myers J; Shennan AH; Chappell LC;
    Hypertension; 2024 Jul; 81(7):1561-1573. PubMed ID: 38708607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental Growth Factor (PlGF)- Based Biomarker Testing to Help Diagnose Pre-eclampsia in People With Suspected Pre-eclampsia: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2023; 23(3):1-146. PubMed ID: 37284279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Planned delivery for pre-eclampsia between 34 and 37 weeks of gestation: the PHOENIX RCT.
    Chappell LC; Brocklehurst P; Green M; Hardy P; Hunter R; Beardmore-Gray A; Bowler U; Brockbank A; Chiocchia V; Cox A; Duhig K; Fleminger J; Gill C; Greenland M; Hendy E; Kennedy A; Leeson P; Linsell L; McCarthy FP; O'Driscoll J; Placzek A; Poston L; Robson S; Rushby P; Sandall J; Scholtz L; Seed PT; Sparkes J; Stanbury K; Tohill S; Thilaganathan B; Townend J; Juszczak E; Marlow N; Shennan A
    Health Technol Assess; 2022 Nov; ():. PubMed ID: 36547875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre-eclampsia.
    Reddy M; Palmer K; Rolnik DL; Wallace EM; Mol BW; Da Silva Costa F
    Ultrasound Obstet Gynecol; 2022 May; 59(5):596-605. PubMed ID: 34985800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of biochemical tests of placental function for improving pregnancy outcome.
    Heazell AE; Whitworth M; Duley L; Thornton JG
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD011202. PubMed ID: 26602956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PARROT Ireland: Placental growth factor in Assessment of women with suspected pre-eclampsia to reduce maternal morbidity: a Stepped Wedge Cluster Randomised Control Trial Research Study Protocol.
    Hayes-Ryan D; Hemming K; Breathnach F; Cotter A; Devane D; Hunter A; McAuliffe FM; Morrison JJ; Murphy DJ; Khashan A; McElroy B; Murphy A; Dempsey E; O'Donoghue K; Kenny LC
    BMJ Open; 2019 Mar; 9(2):e023562. PubMed ID: 30826791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental growth factor measurements in the assessment of women with suspected Preeclampsia: A stratified analysis of the PARROT trial.
    Duhig KE; Myers JE; Gale C; Girling JC; Harding K; Sharp A; Simpson NAB; Tuffnell D; Seed PT; Shennan AH; Chappell LC
    Pregnancy Hypertens; 2021 Mar; 23():41-47. PubMed ID: 33221705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental Growth Factor informed management of suspected pre-eclampsia or fetal growth restriction: The MAPPLE cohort study.
    Sharp A; Chappell LC; Dekker G; Pelletier S; Garnier Y; Zeren O; Hillerer KM; Fischer T; Seed PT; Turner M; Shennan AH; Alfirevic Z
    Pregnancy Hypertens; 2018 Oct; 14():228-233. PubMed ID: 29627351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial.
    Chappell LC; Bell JL; Smith A; Linsell L; Juszczak E; Dixon PH; Chambers J; Hunter R; Dorling J; Williamson C; Thornton JG;
    Lancet; 2019 Sep; 394(10201):849-860. PubMed ID: 31378395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
    Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
    Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentre randomised trial of screening with sFlt1/PlGF and planned delivery to prevent pre-eclampsia at term: protocol of the PE37 study.
    Llurba E; Crispi F; Crovetto F; Youssef L; Delgado JL; Puig I; Mora J; Krofta L; Mackova K; Martinez-Varea A; Tubau A; Ruiz A; Paya A; Prat M; Chantraine F; Comas C; Kajdy A; Lopez-Tinajero MF; Figueras F; Gratacos E;
    BMJ Open; 2024 Mar; 14(3):e076201. PubMed ID: 38458783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prognostic model to guide decision-making on timing of delivery in late preterm pre-eclampsia: the PEACOCK prospective cohort study.
    Duhig K; Seed PT; Placzek A; Sparkes J; Gill C; Brockbank A; Shennan A; Thangaratinam S; Chappell LC
    Health Technol Assess; 2021 May; 25(30):1-32. PubMed ID: 34024312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal assessment of angiogenic markers in prediction of adverse outcome in women with confirmed pre-eclampsia.
    Binder J; Palmrich P; Kalafat E; Haberl C; Schirwani N; Pateisky P; Khalil A
    Ultrasound Obstet Gynecol; 2023 Dec; 62(6):843-851. PubMed ID: 37265117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of three commercially available placental growth factor-based tests in women with suspected preterm pre-eclampsia: the COMPARE study.
    McCarthy FP; Gill C; Seed PT; Bramham K; Chappell LC; Shennan AH
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):62-67. PubMed ID: 29575304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.